Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Tohoku University Venture Partners
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
PronirasVenture round $6.9M · 2 yr ago · Founded 2016 · 11-50 employees
About Us Proniras Corporation ("Proniras") is a clinical-stage biotechnology company focused on the development of novel small-molecule…
Centessa PharmaceuticalsFounded 2021 · 201-500 employees · 10 roles
Centessa Pharmaceuticals is a transformational pharmaceutical brand that aims to discover and develop medicines that can have a profound…
Cajal Tx201-500 employees
Advancing medicines to restore homeostasis. Cajal Therapeutics is developing novel medicines for serious diseases, including anemias of…
At Sentinal4D, we believe patients battling cancer, neurodegenerative diseases, and chronic inflammatory syndromes deserve personalized…
Applied Cognition is a platform therapeutic company developing drugs to enhance brain glymphatic function and treat Alzheimer’s disease.
Atavistik BioSeries B $120M · 10 mo ago · Founded 2021 · 51-200 employees · 1 role
Atavistik Bio is a clinical stage biotechnology company developing novel allosteric therapeutics. Our approach enables selective modulation…

Overview

Luxna Biotech is a preclinical-stage Japanese biotechnology company that develops antisense oligonucleotide (ASO) therapeutics using novel modified nucleoside chemistries and an original drug discovery platform called LuxiAPT. It leverages modified nucleosides invented at Osaka University alongside the LuxiAPT platform to discover and co-develop ASO drugs in collaboration with pharmaceutical companies and academic laboratories across multiple disease targets. The company places particular emphasis on neurological disorders and is pursuing both in-house programs and partnerships to develop therapies for spinal cord injury.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
49 portfolio companies: MDTx, DiveRadGel, Koeda med and 46 more